Semochkin, S. V. Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma. Clinical Oncohematology 2024, 16 (3), 229-241. https://doi.org/10.21320/2500-2139-2023-16-3-229-241.